Indeed, when we analyzed ADAMTS1 expression data considering different stages of tumor progression, we observed a clear tendency for ADAMTS1 to be more expressed at early phases (identified here with stage IIA) and decreases with higher grades (Figure 6d). This evidence concerns the gene ADAMTS1 and neoplasm.